4967
KOBAYASHI PHARMACEUTICAL CO.,LTD.
小林製薬
- Industry
- Chemicals
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Dec 2021
155,252
Dec 2022
166,258
Dec 2023
173,455
Dec 2024
165,600
Dec 2025
165,742
Operating profit(million JPY)
Dec 2021
26,065
Dec 2022
26,669
Dec 2023
25,780
Dec 2024
24,860
Dec 2025
14,923
Operating profit margin(%)
Dec 2021
16.79
Dec 2022
16.04
Dec 2023
14.86
Dec 2024
15.01
Dec 2025
9
Profit before tax(million JPY)
Dec 2021
27,636
Dec 2022
27,950
Dec 2023
27,559
Dec 2024
13,914
Dec 2025
3,744
Profit(million JPY)
Dec 2021
19,715
Dec 2022
20,022
Dec 2023
20,338
Dec 2024
10,067
Dec 2025
3,656
Total assets(million JPY)
Dec 2021
252,554
Dec 2022
255,827
Dec 2023
267,473
Dec 2024
265,368
Dec 2025
275,329
Cash and cash equivalents(million JPY)
Dec 2021
81,987
Dec 2022
79,480
Dec 2023
59,690
Dec 2024
45,973
Dec 2025
64,693
Cash flows from operating activities(million JPY)
Dec 2021
22,419
Dec 2022
31,914
Dec 2023
18,360
Dec 2024
11,246
Dec 2025
25,590
Cash flows from investing activities(million JPY)
Dec 2021
7,991
Dec 2022
-14,312
Dec 2023
-19,576
Dec 2024
-18,415
Dec 2025
-154
Cash flows from financing activities(million JPY)
Dec 2021
-10,377
Dec 2022
-20,759
Dec 2023
-19,463
Dec 2024
-7,768
Dec 2025
-7,921
Return on equity(%)
Dec 2021
10.4
Dec 2022
10.2
Dec 2023
10.1
Dec 2024
4.8
Dec 2025
1.7
Equity ratio(%)
Dec 2021
77.4
Dec 2022
77.3
Dec 2023
76.4
Dec 2024
80.2
Dec 2025
76.3
Earnings per share(JPY per share)
Dec 2021
252.36
Dec 2022
259.63
Dec 2023
268.16
Dec 2024
135.42
Dec 2025
49.19
Net assets per share(JPY per share)
Dec 2021
2,515.53
Dec 2022
2,600.04
Dec 2023
2,749.17
Dec 2024
2,862.28
Dec 2025
2,827.68
Dividend per share(JPY per share)
Dec 2021
83
Dec 2022
90
Dec 2023
101
Dec 2024
102
Dec 2025
104
Payout ratio(%)
Dec 2021
32.89
Dec 2022
34.66
Dec 2023
37.66
Dec 2024
75.32
Dec 2025
211.43
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.